China speeds up COVID-19 medicine development
BEIJING: With the world still in the grip of the COVID-19 pandemic, Chinese scientists are accelerating the development of COVID-19 medicines. Tsinghua University, the Third People’s Hospital of Shenzhen and Brii Biosciences have jointly developed a cocktail therapy of monoclonal antibodies BRII-196 and BRII-198, which are derived from antibodies isolated from people who had recovered … Read more